Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats

Journal of Neurosurgery

Volumn 84, Issue 6, 1996, Pages 1006-1012

  Date, Isao ^a   Ohmoto, Takashi ^b   Imaoka, Takashi ^b   Ono, Takeshi ^b   Hammang, Joseph P ^b   Francis, Jonathan ^b   Greco, Corinne ^b   Emerich, Dwaine F ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

chromaffin cell; encapsulation; nerve growth factor; neural transplantation; Parkinson's disease

Indexed keywords

NERVE GROWTH FACTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; POLYMER;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CHROMAFFIN CELL; CIRCLING BEHAVIOR; CONTROLLED STUDY; HAMSTER; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RAT;

EID: 0029940366     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.6.1006     Document Type: Article

References (49)

1. Aebischer P, Tresco PA, Sagen J, et al: Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 560:43-49, 1991
2. Aebischer P, Tresco PA, Winn SR, et al: Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp Neurol 111:269-275, 1991
3. Aebischer P, Winn SR, Galletti PM: Transplantation of neural tissue in polymer capsules. Brain Res 448:364-368, 1988
4. Baetge EE, Suh YH, Job TH: Complete nucleotide and deduced amino acid sequence of bovine phenylethanolamine N-methyltransferase: partial amino acid homology with rat tyrosine hydroxylase. Proc Natl Acad Sci USA 83:5454-5458, 1986
5. Bankiewicz KS, Plunkett RJ, Kopin IJ, et al: Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. Prog Brain Res 78:543-549, 1988
6. Bing G, Notter MFD, Hansen JT, et al: Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesions. Neuroscience 34:687-697, 1990
7. Björklund A, Stenevi U: Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560, 1979
8. Bonn MC, Cupit L, Marciano F, et al: Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913-916, 1987
9. Cunningham LA, Hansen JT, Short MP, et al: The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res 561:192-202, 1991
10. Date I, Felten DL, Felten SY: Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res 519:266-276, 1990
11. Date I, Felten SY, Felten DL: Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res 537:33-39, 1990
12. 1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. Neurosci Lett 106:282-286, 1989
13. Date I, Felten SY, Felten DL: The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft. Brain Res 545:191-198, 1991
14. Date I, Felten SY, Olschowka JA, et al: Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice. Exp Neurol 107:197-207, 1990
15. Date I, Furukawa S, Ohmoto T: Increased nerve growth factor level in the distal stump of transected sciatic nerve in relation to aging and its application for neural grafting. Exp Neurol 130: 168-171, 1994
16. Date I, Miyoshi Y, Imaoka T, et al: Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease. Neurosci Res 20: 213-221, 1994
17. Date I, Notter MFD, Felten SY, et al: MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res 526:156-160, 1990
18. Date I, Notter MFD, Felten SY, et al: Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP-treated aging mice. J Neurosci Res 28:525-530, 1991
19. Date I, Yoshimoto Y, Gohda Y, et al: Long-term effects of cografts of pretransected peripheral nerve with adrenal medulla in animal models of Parkinson's disease. Neurosurgery 33: 685-690, 1993
20. Date I, Yoshimoto Y, Imaoka T, et al: Effect of host age upon the degree of nigrostriatal dopaminergic system recovery following cografts of adrenal medulla and pretransected peripheral nerve. Brain Res 637:50-56, 1994
21. Date I, Yoshimoto Y, Imaoka T, et al: Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging. Brain Res 621:150-154, 1993
22. Date I, Yoshimoto Y, Miyoshi Y, et al: The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve. Brain Res 624:233-238, 1993
23. Doering LC: Peripheral nerve segments promote consistent long term survival of adrenal medulla transplants in the brain. Exp Neurol 118:253-260, 1992
24. Dubach M, German DC: Extensive survival of chromaffin cells in adrenal medulla "ribbon" grafts in the monkey neostriatum. Exp Neurol 110:167-180, 1990
25. Ellis JE, Byrd LD, Bakay RAE: A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and co-grafting. Exp Neurol 115: 376-387, 1992
26. Emerich DF, Frydel BR, Flanagan TR, et al: Transplantation of polymer encapsulated PC12 cells: use of chitosan as an immobilization matrix. Cell Transplant 2:241-249, 1993
27. Emerich DF, Winn SR, Christenson L, et al: A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy. Neurosci Biobehav Rev 16: 437-447, 1992
28. Emerich DF, Winn SR, Harper J, et al: Implants of polymerencapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349:148-164, 1994
29. Fiandaca MS, Kordower JH, Hansen JT, et al: Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp Neurol 102:76-91, 1988
30. Freed WJ, Cannon-Spoor HE, Krauthamer E: Intrastriatal adrenal medulla grafts in rats. Long-term survival and behavioral effects. J Neurosurg 65:664-670, 1986
31. Freed WJ, Morihisa JM, Spoor E, et al: Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 292:351-352, 1981
32. Gage FH, Wolff JA, Rosenberg MB, et al: Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795-807, 1987
33. Hurtig H, Joyce J, Sladek JR, et al: Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 25:607-614, 1989
34. Jankovic J, Grossman R, Goodman C, et al: Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology 39:1227-1234, 1989
35. Kordower JH, Cochran E, Penn RD, et al: Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann Neurol 29:405-412, 1991
36. Kordower JH, Fiandaca MS, Notter MFD, et al: NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J Neurosurg 73:418-428, 1990
37. Kordower JH, Winn SR, Liu YT, et al: The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA 91: 10898-10902, 1994
38. Lindner MD, Dworetzky SI, Sampson C, et al: Relationship of APP mRNA transcripts and levels of NGF and low-affinity NGF receptors to behavioral measures of age-related cognitive dysfunction. J Neurosci 14:2282-2289, 1994
39. Lindvall O: Transplantation into the human brain: present status and future possibilities. J Neurol Neurosurg Psychiatry Suppl:39-54, 1989
40. Madrazo I, Franco-Bourland R, Aguilera M, et al: Development of human neural transplantation. Neurosurgery 29:165-177, 1991
41. Olson L, Backlund EO, Ebendal T, et al: Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. Arch Neurol 48:373-381, 1991
42. Peterson DI, Price ML, Small CS: Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology 39:235-238, 1989
43. Schueler SB, Ortega JD, Sagen J, et al: Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability. J Neurosci 13:4496-4510, 1993
44. Spencer DD, Robbins RJ, Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548, 1992
45. Strömberg I, Herrera-Marschitz M, Ungerstedt U, et al: Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behavior. Exp Brain Res 60:335-349, 1985
46. Tresco PA, Winn SR, Tan S, et al: Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant 1:255-264, 1992
47. Unsicker K: The trophic cocktail made by adrenal chromaffin cells. Exp Neurol 123:167-173, 1993
48. Unsicker K, Krisch B, Otten U, et al: Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci USA 75:3498-3502, 1978
49. Winn SR, Hammang JP, Emerich DF, et al: Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc Natl Acad Sci USA 91:2324-2328, 1994